Natus Medical Incorporated (NASDAQ:BABY) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
On January 5, 2018, Natus Medical Incorporated (the "Company") issued a press release announcing the appointment of Leslie McDonnell as Vice President and General Manager of its Newborn Care Business Unit effective February 12, 2018.
Ms. McDonnell has over 20 years of experience in the medical device industry, including business unit managements, marketing and business development roles at 3M Healthcare and Medtronic Inc. Most recently, she served as Global Business Vice-President, Critical & Chronic Care Solutions at 3M Healthcare.
Ms. McDonnell entered into an employment agreement that is effective upon joining the Company providing for initial compensation of an annual base salary of $325,000 and participation in the Company's cash bonus plan for 2018 with a target bonus of 50% of base salary. In addition, she will also receive an initial grant of $500,000 worth of restricted stock that shall vest at the rate of 50% on the first anniversary of the grant and 50% on the second anniversary of the grant. Final share amount shall be determined based on her date of hire.
|
Item 5.02. |
Financial Statements and Exhibits |
(d) Exhibits.
|
ExhibitNo. |
Description |
|
10.1 |
Employment Agreement between Natus Medical Inc. and Leslie McDonnell |
|
99.1 |
Press release dated January 5, 2018 announcing the appointment of Leslie McDonnell |
NATUS MEDICAL INC ExhibitEX-10.1 2 exhibit101_lesliemcdonnell.htm EXHIBIT 10.1 Exhibit Exhibit 10.1NATUS MEDICAL INCORPORATEDLESLIE MCDONNELL EMPLOYMENT AGREEMENTThis Agreement is entered into as of January 3,…To view the full exhibit click here
About Natus Medical Incorporated (NASDAQ:BABY)
Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders. The Company’s segment is neurology and newborn care product families. Its product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products, such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn’s environment, and software systems for managing and tracking disorders and diseases for public health laboratories. It is organized into two strategic business units: Neurology and Newborn Care.
